Experimental Coronavirus Drug Neumifil Shows Promise In Lab Scientists Hope To Rapidly Start Clinical Trials
The drug works by masking specific receptors in the airways to stop the virus from entering cells. The team in Scotland found sugar-binding proteins known as Carbohydrate Binding Modules (mCBMs), including one which they have dubbed Neumifil, prevented cells in a lab from being infected with SARS-CoV-2—the virus which causes COVID-19. There are currently no specific drugs or vaccines for COVID-19, and the team are among scientists racing to find ways to tackle the disease....